TABLE 2

Ex vivo binding analysis after a single oral administration of Lu AA33810 in rats

All tissues were collected 1 h postdose. Plasma and brain samples were analyzed for exposure levels of Lu AA33810. Brain sections through the caudate putamen were analyzed for specific binding using the Y5 receptor-selective radioligand [35S]Lu AE66516. The reduction in specific binding of [35S]Lu AE66516 (relative to maximal values in vehicle-treated controls) was used to determine percentage receptor occupancy of Lu AA33810. Data represent mean ± S.E.M. of n = 3 experiments.


Lu AA33810

Plasma Levels

Brain Levels

Occupancy
ng/ml ng/g % Maximal
1 mg/kg p.o. 22 ± 10 29 ± 12 22 ± 12
3 mg/kg p.o. 44 ± 14 69 ± 19 28 ± 3
10 mg/kg p.o. 64 ± 24 103 ± 21 54 ± 6
30 mg/kg p.o.
156 ± 6
285 ± 4
95 ± 2